Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 15, Issue 8, pp 469–477 | Cite as

Preservation of Fertility in Women Undergoing Chemotherapy: Current Approach and Future Prospects

  • Ronit Abir
  • Benjamin Fisch
  • Ahud Raz
  • Shmuel Nitke
  • Zion Ben-Rafael
Article

Abstract

Purpose: Anticancer treatment causes ovarian failure.

Methods: Some hormones may have a protective effect on the ovary. Cryopreservation (freezing) of oocytes has had very limited success, and therefore, currently its use before chemotherapy is not a feasible option. However, cryopreservation of embryos is possible. Another solution is oocyte donation followed by in vitro fertilization (IVF).

Results: Ovarian cortical slices containing primordial follicles have been cryopreserved successfully. To restore fertility, cryopreserved–thawed tissue taken from cancer patients before therapy could be replanted after recovery. The possible risk of malignancy restoration could be eliminated by obtaining unilaminar follicles from cryopreserved–thawed tissue and growing them in vitro, followed by routine IVF.

Conclusions: Although women who undergo chemotherapy face limited options for fertility preservation, intensive studies in cryopreservation and in vitro maturation of follicles harbor hope for brighter prospects in the future.

primordial follicles chemotherapy “protective” hormonal treatment cryopreservation in vitro maturation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Barlow DH: Premature ovarian failure. Bailliere's Clin Obstet Gynecol 1996;10:369–384Google Scholar
  2. 2.
    Chatterjee R, Goldstone AH: Gonadal damage and the effects of fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 1996;17:5–11Google Scholar
  3. 3.
    Gougeon A: Regulations of ovarian follicular development in primates: Facts and hypotheses. Endocrine Rev 1996;17:121–154Google Scholar
  4. 4.
    Ataya KM, McKana JA, Weintraub AM, Clark MR, LeMaire WJ: A luteinising hormone-releasing hormone agonist for the prevention of chemotherapy-induced follicular loss in rats. Cancer Res 1985;45: 3651–3656Google Scholar
  5. 5.
    Ataya K, Moghissi K: Chemotherapy-induced premature ovarian failure: mechanism and prevention. Steroids 1989;54:607–626Google Scholar
  6. 6.
    Ataya KM, Pyden E, Sacco A: Effect of “activated” cyclophosphamide on mouse oocyte in vitro fertilization and cleavage. Reprod Toxicol 1988;2:105–109Google Scholar
  7. 7.
    Ramahi-Ataya A, Ataya KM, Subramanian M, Sturck R: The effect of “activated” cyclophosphamide on rat granulosa cells in vitro. Reprod Toxicol 1988;2:99–103Google Scholar
  8. 8.
    Nicosia SV, Matus-Ridley M, Meadows AT: Gonadal effects of cancer therapy in girls. Cancer 1985: 55:2364–2372Google Scholar
  9. 9.
    Marcello MF, Nucifero G, Romeo R, Dino GD, Russo I, Russo A, Palumbo G, Schiliro G: Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer 1990;66:2099–2104Google Scholar
  10. 10.
    Owens S, Roberts WS, Fiorica JV, Hoffman MS, Lapolla JP, Cavanagh D: Ovarian management at the time of radical hysterectomy for cancer of the cervix. Gynecol Oncol 1989;35:349–351Google Scholar
  11. 11.
    van Beurden M, Schuster Uitterhoeve AL, Lemmes FB: Feasibility of transportation of the ovaries in the surgical and radiotherapeutical treatment of cervical cancer. Eur J Surg Oncol 1990;16:141–146Google Scholar
  12. 12.
    Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP: The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 1995;56:3–7Google Scholar
  13. 13.
    Chapman RM, Sutcliffe SB: Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 1991;58:849–851Google Scholar
  14. 14.
    Chapman RM, Sutcliffe SB, Malpass JS: Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA 1979;242:1788–1881Google Scholar
  15. 15.
    Blumenfeld Z, Haim N: Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997;29:199–206Google Scholar
  16. 16.
    Montz FJ, Wolff AJ, Gambone JC: Gonadal protection and fecundity rates in cyclophosphamide-treated rats. Cancer Res 1991;51:2124–2126Google Scholar
  17. 17.
    Ataya K, Rao LV, Lawrence E, Kimmel R: Hormone-releasing agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995;52:365–372Google Scholar
  18. 18.
    Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel with chemotherapy. Hum Reprod 1996;11:1620–1626Google Scholar
  19. 19.
    Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM: Ultrastructure of human ovarian primordial follicles after combination of chemotherapy for Hodgkin's disease. Hum Reprod 1993;8:2080–2087Google Scholar
  20. 20.
    Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C: Birth of a healthy female after intracytoplasmatic sperm injection to cryopreserved human oocytes. Fertil Steril 1997;68:724–726Google Scholar
  21. 21.
    Bernard A, Fuller BJ: Cryopreservation of human oocytes: A review of current problems and perspectives. Hum Reprod Update 1996;2:193–207Google Scholar
  22. 22.
    Gook DA, Osborn SM, Johnson WIH: Parthogenic activity of human oocytes following cryopreservation using 1,2-propandiol. Hum Reprod 1995;10:654–658Google Scholar
  23. 23.
    Al-Hasani S, Diedrich K, van der Ven H, Reinecke A, Hartje M, Krebs D: Cryopreservation of human oocytes. Hum Reprod 1987;2:695–700Google Scholar
  24. 24.
    Chen C: Pregnancy after human oocyte cryopreservation. Lancet 1986;1:884–886Google Scholar
  25. 25.
    Van Uem JFHM, Siebzehnruebl ER, Schuh B, Koch R, Trontow S, Lang N: Birth after cryopreservation of unfertilised oocytes. Lancet 1987;1:752–753Google Scholar
  26. 26.
    Tucker M, Wright G, Morton P, Shanguo L, Massey J, Kort H: Preliminary experience with human oocye cryopreservation using 1,2-propanediol and sucrose. Hum Reprod 1996;7:1513–1515Google Scholar
  27. 27.
    Gook DA, Schiewe MC, Osborn SM, Asch R, Jansen RPS, Johnson WIH: Intracytoplasmic sperm injection and embryo development of human crypreserved using 1,2-propandiol. Human Reprod 1995;10:2637–2641Google Scholar
  28. 28.
    Kazem R, Thompson LA, Laing MA, Hamilton MPR, Templeton A: Cryopreservation of human oocytes and fertilization by two techniques: in vitro fertilization and intra cytoplasmic sperm injection. Hum Reprod 1995;10:2650–2654Google Scholar
  29. 29.
    Candy CJ, Wood MJ, Whittingham DG, Merriman JA, Choundhury N: Cryopreservation of immature mouse oocytes. Hum Reprod 1994;9:1738–1742Google Scholar
  30. 30.
    Toth TL, Baka SG, Veeck LL, Jones HW, Muasher S, Lanzendorf SE: Fertilization and in vitro development of cryopreserved prophase I oocytes. Fertil Steril 1994;61:891–894Google Scholar
  31. 31.
    Son WY, Park SE, Lee KA, Lee WS, Ko JJ, Yoon TK, Cha KY: Effects of 1,2 propandiol and freezing-thawing on the in vitro development capacity of human immature oocytes. Fertil Steril 1996;66:995–999Google Scholar
  32. 32.
    Toth TL, Lanzendorf SE, Sandow BA, Veeck LL, Hassen WA, Hodgen GD: Cryopreservation of human prophase I oocytes collected from unstimulated cycles. Fertil Steril 1994;61:1077–1082Google Scholar
  33. 33.
    Gelety T, Surrey E: Cryopreservation of embryos and oocytes: an update. Curr Opin Obstet Gynecol 1993;5:606–614Google Scholar
  34. 34.
    Brown JR, Modell E, Obasaju M, Ying YK: Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast. Hum Reprod 1996;11:197–199Google Scholar
  35. 35.
    Morris R, Sauer M: New advances in the treatment of fertility in women with ovarian failure. Curr Opin Obstet Gynecol 1993;5:368–377Google Scholar
  36. 36.
    Rio B, Letur-Konirsch H, Ajechenbaum-Cymbalista F, Bauduer F, De-Ziegler D, Pellissier C, Bernadou A, Frydman R, Zittoun R: Full term pregnancy with embryos from donated oocytes in 36-year old woman allografted for chronic myeloid leukaemia. Bone Marrow Transplant 1994;13:487–488Google Scholar
  37. 37.
    Atkinson HG, Apperley JF, Dawson K, Goldman JM, Winston RM: Successful pregnancy after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Lancet 1994;344:1994 [letter]Google Scholar
  38. 38.
    Shushan A, Schenker JG: The use of oocytes obtained from a aborted fetuses in egg donation programs. Fertil Steril 1994;62:449–451Google Scholar
  39. 39.
    Cox S-L, Shaw J, Jenkin G: Transplantation of cryopreserved fetal ovarian tissue to adult recipients in mice. J Reprod Fertil 1996;107:315–322Google Scholar
  40. 40.
    Wandji S-A, Srsen V, Voss AK, Eppig JJ, Fortune JE: Initiation of in vitro growth of bovine primordial follicles. Biol Reprod 1996;55:942–948Google Scholar
  41. 41.
    Wandji S-A, Srsen V, Nathanielsz PW, Eppig JJ, Fortune JE: Initation of growth of baboon primordial follicles in vitro. Hum Reprod 1997;12:1993–2001Google Scholar
  42. 42.
    Zhang J, Liu J, Xu KP, Liu B, DiMattina M: Extracorporeal development and ultrarapid freezing of human fetal ova. J Assist Reprod Genet 1995;12:361–368Google Scholar
  43. 43.
    Gosden RG: Oocyte development throughout life. In Gametes—The Oocyte, JG Grudzinshes, JL Yovici (eds). Cambridge, Cambridge University Press, 1995, pp 119–149Google Scholar
  44. 44.
    Gosden RG, Baird DT, Wade JC, Webb R: Restoration of fertility to oophorectomized sheep by ovarian autographs stored at −196°C. Hum Reprod 1994;9:597–603Google Scholar
  45. 45.
    Nugent D, Meirow D, Brook PF, Aubard Y, Gosden RG: Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects. Hum Reprod Update 1997;3:267–280Google Scholar
  46. 46.
    Gosden RG: Restitution of fertility in sterilised mice by transferring primordial ovarian follicles. Hum Reprod 1990;5:117–122Google Scholar
  47. 47.
    Gosden RG: Transplantation of ovaries and testes. In Fetal Tissue Transplants in Medicine, RG Edwards (ed), Cambridge, Cambridge University Press, 1992, pp 253–279Google Scholar
  48. 48.
    Carroll J, Gosden RG: Transplantation of frozen-thawed mouse primordial follicles. Hum Reprod 1993;8:1163–1167Google Scholar
  49. 49.
    Guanasena KT, Villines PM, Critser ES, Crister JK: Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod 1997;12:101–106Google Scholar
  50. 50.
    Gosden RG, Boulton MI, Grant K, Webb R: Follicular development from ovarian xenografts in SCID mice. J Reprod Fert 1994;101:619–623Google Scholar
  51. 51.
    Oktay K, Newton H, Mullan J, Gosden RG: Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod 1998;13:1133–1138.Google Scholar
  52. 52.
    Candy CJ, Wood MJ, Whittingham DG: Follicular development in cryopreserved marmoset ovarian tissue after transplantation. Hum Reprod 1995;10:2334–2338Google Scholar
  53. 53.
    Hovatta O, Silye R, Kraustz T, Abir R, Margara RA, Trew G, Lass A, Winston RML: Cryopreservation of human ovarian tissue by using dimethylsulphoxide and propandiol-sucrose as cryoprotectants. Hum Reprod 1996;11:1268–1272Google Scholar
  54. 54.
    Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R: Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996;11:1487–1491Google Scholar
  55. 55.
    Newton H, Fisher J, Arnold JRP, Peggy DE, Faddy MJ, Gosden RG: Permeation of human ovarian tissue with cryopretective agents in preparation for cryopreservation. Hum Reprod 1998;13:376–380Google Scholar
  56. 56.
    Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO: Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996;11:1668–1673Google Scholar
  57. 57.
    Shaw J, Trounson A: Oncological implications in the replacement of ovarian tissue. Hum Reprod 1997;12:403–405Google Scholar
  58. 58.
    Gosden RG, Rutherford AJ, Norfolk DR: Ovarian banking for cancer patients-transmission of malignant cells in ovarian grafts. Hum Reprod 1997;12:403Google Scholar
  59. 59.
    Moomjy M, Rosenwaks Z: Ovarian tissue cryopreservation the time is now. Transplantation or in vitro maturation: the time awaits. Fertil Steril 1998;69:999–1000Google Scholar
  60. 60.
    Gosden RG, Boland NI, Spears N, Murray AA, Chapman M, Wade JC, Zohdy NI, Brown N: The biology of follicular oocyte development in vitro. Reprod Med Rev 1993;2:129–152Google Scholar
  61. 61.
    Hartshorne GM: In vitro culture of ovarian follicles. Rev Reprod 1997;2:94–104Google Scholar
  62. 62.
    Eppig DG, Schroeder AC: Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro. Biol Reprod 1989;41:268–276Google Scholar
  63. 63.
    Spears N, Boland NI, Murray AA, Gosden RG: Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile. Hum Reprod 1994;9:527–532Google Scholar
  64. 64.
    Roy SK, Greenwald GS: Hormonal requirements for the growth and differentiation of hamster preantral follicles in long term culture. J Reprod Fert 1989;87:103–114Google Scholar
  65. 65.
    Hirao Y, Nagai T, Kubo M, Miyano T, Miyake M, Kato S: In vitro growth of and maturation of pig oocytes. J Reprod Fert 1994;100:333–339Google Scholar
  66. 66.
    Roy SK, Treacy BJ: Isolation and long term culture of human preantral follicles. Fertil Steril 1993;59:783–790Google Scholar
  67. 67.
    Abir R, Franks S, Mobberley MA, Moore PA, Margara RA, Winston RML: Mechanical isolation and in vitro growth of preantral and small antral human follicles. Fertil Steril 1997;68:682–688Google Scholar
  68. 68.
    Hughesdon PE: Morphology and morphogenesis of the Stein-Leventhal ovary and so-called “hyperthecosis.” Obstet Gynecol Surv 1982;37:59–77Google Scholar
  69. 69.
    Qvist R, Blackwell LF, Bourne H, Brown JB: Development of mouse follicles from primary to preovulatory stages in vitro. J Reprod Fert 1990;89:169–180Google Scholar
  70. 70.
    Eppig JJ, O'Brien M: Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 1996;54:197–207Google Scholar
  71. 71.
    Hovatta O, Silye R, Abir R, Krausz T, Winston RML: Extracellular matrix improves the survival of human primordial and primary fresh and frozen-thawed ovarian follicles in long-term culture. Hum Reprod 1997;12:1032–1036Google Scholar
  72. 72.
    Torrance C, Telfer E, Gosden RG: Quantitative study of the development of isolated mouse pre-antral follicles in collagen gel culture. J Reprod Fert 1989;87:367–374Google Scholar
  73. 73.
    Hulshof SCJ, Figueiredo JR, Beckers JF, Bevers MM, van den Donk JA, van den Hurk R: Effects of fetal bovine serum, FSH and 17β-estradiol on the culture of bovine preantral follicles. Theriogenol 1995;44:216–226Google Scholar
  74. 74.
    Cain L, Chatterjee S, Collins TJ: In vitro folliculogenesis of rat preantral follicles. Endocrinology 1995;136:3369–3377Google Scholar
  75. 75.
    Greenwald GS, Moor RM: Isolation and preliminary characterization of pig primordial follicles. J Reprod Fert 1989;87:561–571Google Scholar
  76. 76.
    Morbeck DE, Flowers WL, Britt JH: Response of granulosa cells isolated from primary and secondary follicles to FSH, 8-bromo-cAMP and epidermal growth factor in vitro. J Reprod Fertil 1993;99:577–584Google Scholar
  77. 77.
    Oktay K, Nugent D, Newton H, Selha O, Chatterjee P, Gosden RG: Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril 1997;67:481–486Google Scholar
  78. 78.
    Abir R, Fisch B, Nitke S, Roizman P, Ben Rafael Z: Isolation and culture of human unilaminar and early secondary follicles. Hum Reprod 1988;13 Abstract book 1:0-045, 22Google Scholar
  79. 79.
    Bahadur G, Steele SJ: Ovarian tissue cryopreservation. Hum Reprod 1996;11:2215–2216Google Scholar
  80. 80.
    Wood CE, Shaw JM: Cryopreservation of ovarian tissue potential “reproductive insurance” for women at risk of early ovarian failure. MJA 1997;166:366–369.Google Scholar
  81. 81.
    Meirow D, Ben Yehuda D, Prus D, Poliack A, Schenker J, Rachmilewitz EA, Lewin A: Ovarian tissue banking in patients with Hodgkin's disease: Is it safe. Fertil Steril 1998;69:996–998Google Scholar
  82. 82.
    Oktay K, Newton H, Aubard Y, Salha O, Gosden RG: Cryopreservation of immature human oocytes and ovarian tissue: An emerging technology? Fertil Steril 1998;69:1–7.Google Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • Ronit Abir
    • 1
  • Benjamin Fisch
    • 1
  • Ahud Raz
    • 1
  • Shmuel Nitke
    • 1
  • Zion Ben-Rafael
    • 1
  1. 1.IVF Research Laboratory, Department of Obstetrics and GynecologyRabin Medical Center, Beilinson CampusIsrael

Personalised recommendations